1. American Psychiatric Foundation (2000) Diagnostic and statistical manual of mental disorders DSM-IV-TR 4th edition. First MB, Wipliger TA (eds)
2. Andersen J, Aabro E, Gulmann N, Hjelmsted A, Pedersen J (1980) Antidepressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-dopa. Acta Neurol Scand 64:210–219
3. Avila A, Cardona X, Martin-Baranera M, Maho P, Sastre F, Bello J (2003) Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial. J Clin Psychopharmacol 23:509–513
4. Barone P, Goetz C, Houben J, Koester J, Leentjens A, Poewe W, Rascol O, Reichmann H, Schapira A, Tolosa E (2006) PRODEST – Depression symptoms in Parkinson's disease (Abstract). MDS Congress, Kyoto
5. Barone P, Scarzella L, Marconi R, Antonini A, Morgante L, Bracco F, Zappia M, Musch B; Depression/Parkinson Italian Study Group (2006) Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study. J Neurol 253:601–607